Dermatology CME (Continuing Medical Education)

Dr. F Martin Del rosario

0 Earned Credits.

Dermatology CME

Special Report: The Topical Treatment of Psoriasis, Volume 4 CME A recent conference brought together clinicians and basic scientists to explore the relationship between atherosclerosis and psoriasis.
MedscapeCME Dermatology, November 2009
Special Report: The Topical Treatment of Psoriasis, Volume 4 CME A recent conference brought together clinicians and basic scientists to explore the relationship between atherosclerosis and psoriasis.
MedscapeCME Dermatology, November 2009
An 84-Year-Old Woman With a Blistering Rash CME/CE An 84-year-old woman presents with a blistering rash that began 1 week ago. It is painless but very itchy. Several tense bullae, papules, and vesicles are noted on her skin. What is the diagnosis?
eMedicine Case Presentations CME, November 2009

CME and Expert Commentaries

Neurotoxins: Now and in the Future CME/CE Gary D. Monheit, MD, reviews the current landscape of aesthetic treatment with botulinum neurotoxin type A products.
MedscapeCME Dermatology, September 2009
MRSA in the Community: Best Practices for Early Management and Treatment of Skin and Soft-Tissue Infections CME/CE A panel of experts compare adult and pediatric approaches to management of complicated and uncomplicated MRSA skin and soft tissue infections.
MedscapeCME Infectious Diseases, September 2009
The Multidisciplinary Approach to Psoriatic Arthritis Care: Bridging Dermatology and Rheumatology CME/CE This videotaped expert panel discussion covers factors that differentiate cutaneous and musculoskeletal inflammatory disease in PsA.
August 2009
The Impact of Recent Clinical Data on Therapeutic Decision-Making in Actinic Keratoses CME Drs. Rosen, Stockfleth, and Rigel discuss the pathogenesis of actinic keratoses, treatment approaches, and comparative data on treatment modalities for managing patients and improving outcomes.
MedscapeCME Dermatology, July 2009
New Developments in Aesthetic Therapy With Botulinum Neurotoxin A CME/CE Hema A. Sundaram, MD, discusses how the approval of a new botulinum neurotoxin A for aesthetic use and the mandating of new safety labeling for all botulinum neurotoxins will affect treatment plans.
MedscapeCME Dermatology, July 2009

Policies and Requirements

Not Certified for Credit

Ethnic Rhinoplasty
Experts And Viewpoints, October 2009
Acne, Antibiotics, and Breast Cancer
Experts And Viewpoints, October 2009
Matching the Patient, the Product, and the Procedure
Experts And Viewpoints, September 2009
Follicular Concentrations of Antibiotics
Experts And Viewpoints, September 2009
Switching Antibiotics After Relapse of Acne
Experts And Viewpoints, August 2009

Advisory Board

Scientific Director

CLOSE [X]
SPECIALTY SITES Allergy & Clinical Immunology Anesthesiology Cardiology Critical Care Dermatology Diabetes & Endocrinology Emergency Medicine Family Medicine Gastroenterology General Surgery Hematology-Oncology HIV/AIDS Infectious Diseases	Internal Medicine Lab Medicine Nephrology Neurology Ob/Gyn & Women's Health Oncology Ophthalmology Orthopaedics Pathology & Lab Medicine Pediatrics Plastic Surgery & Aesthetic Medicine Psychiatry & Mental Health Public Health & Prevention Pulmonary Medicine	Radiology Rheumatology Surgery Transplantation Urology Women's Health OTHER SITES Business of Medicine Medscape Today Med Students Nurses Pharmacists

CLOSE [X]Browse CME by Specialty
Allergy & Clinical Immunology Anesthesiology Cardiology Critical Care Dermatology Diabetes & Endocrinology Emergency Medicine Family Medicine Gastroenterology General Surgery Hematology-Oncology HIV/AIDS	Infectious Diseases Internal Medicine Lab Medicine Nephrology Neurology Nurses Ob/Gyn & Women's Health Oncology Ophthalmology Orthopaedics Pathology & Lab Medicine Pediatrics	Pharmacists Plastic Surgery & Aesthetic Medicine Psychiatry & Mental Health Public Health & Prevention Pulmonary Medicine Radiology Rheumatology Surgery Transplantation Urology Women's Health